MedTrace Logo

Prevention of Catheter-Related Bloodstream Infection in Patients With Hemato-Oncological Disease

NCT00413738 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2009-01-27

No results posted yet for this study

Summary

The aim of this prospective randomised controlled trial is to compare the incidence of catheter-related bloodstream infection in 2 groups of patients with hemato-oncological disease:

Group A: heparin-coated central venous catheters (Control Group) Group B: antiseptic-coated (chlorhexidine-silver sulfadiazine) central venous catheters

Conditions

Interventions

DEVICE

Antiseptic-coated central venous catheters

Sponsors & Collaborators

  • Centre National de Greffe de Moelle Osseuse

    lead OTHER_GOV

Principal Investigators

  • Abderrahman Abdelkefi, MD · Centre National de Greffe de Moelle Osseuse

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-12-31
Completion
2009-01-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00413738 on ClinicalTrials.gov